NCT01999621

Brief Summary

Investigators will evaluate determinants of the patients' care type : palliative, medical or intensive care. The place of patient or family on care's decision will be noticed. Investigators will evaluate 3 month-survival and patients' feelings (visit with a psychologist) according to type of care they benefited.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

October 15, 2013

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 3, 2013

Completed
Last Updated

December 3, 2013

Status Verified

November 1, 2013

Enrollment Period

1.9 years

First QC Date

October 15, 2013

Last Update Submit

November 25, 2013

Conditions

Lung Cancer

Keywords

organ failureintensive carepalliative carepatient's wishes

Outcome Measures

Primary Outcomes (1)

  • Identify an association between patients' characteristics and proposition for intensive care unit admission.

    univariate and multivariate logistic regression

    at day 0

Secondary Outcomes (1)

  • Identify an association between patients' characteristics and decision of intensive care unit admission among patients proposed for ICU admission

    at day 0

Other Outcomes (2)

  • identify patients' characteristics associated with survival

    up to 4 months after the last inclusion

  • patients' feelings according to intensity of care they received

    at 3 months

Study Arms (1)

lung cancer

Each lung cancer patient with organ failure, admitted in emergency, thoracic oncology or directly in ICU

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Each lung cancer patient with organ failure, admitted in emergency, thoracic oncology or directly in ICU will be included

You may qualify if:

  • lung cancer
  • Organ failure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Grenoble

Grenoble, 38043, France

Location

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • TIMSIT Jean-François, PU/PH

    University Hospital, Grenoble

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2013

First Posted

December 3, 2013

Study Start

December 1, 2010

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

December 3, 2013

Record last verified: 2013-11

Locations

FR(1)